Stay updated with breaking news from Define Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pharmacy benefit managers have been widely criticized for opaque drug pricing practices. But Waltz Health, which was co-founded by former PBM executive Mark Thierer, aims to use insider knowledge and tech solutions to lower drug costs.
Former CEO of OptumRx today announced the launch of Waltz Health with $35.4M led by GV (Google Ventures) to lower drug costs.
Also: Impiricus raises a $3 million seed, and health tech VC Flare Capital Partners closes its $350 million third fund.
The company has $20 million in funding, including $16 million from a Series A funding round announced Wednesday, and backing from the veteran health executive who has already been at the helm of two startups-turned-unicorns.
9am.health, a virtual diabetes clinic that delivers personalized, affordable, and compassionate care directly to consumers raises $16M.